VanEck Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$62.6M Sell
140,701
-990
-0.7% -$441K 0.07% 182
2025
Q1
$68.7M Sell
141,691
-17,578
-11% -$8.52M 0.09% 156
2024
Q4
$64.1M Buy
159,269
+7,841
+5% +$3.16M 0.08% 159
2024
Q3
$71.2M Buy
151,428
+6,588
+5% +$3.1M 0.09% 144
2024
Q2
$67.9M Sell
144,840
-7,058
-5% -$3.31M 0.1% 148
2024
Q1
$63.5M Sell
151,898
-22,329
-13% -$9.33M 0.1% 144
2023
Q4
$70.9M Buy
174,227
+20,466
+13% +$8.33M 0.13% 126
2023
Q3
$53.5M Sell
153,761
-10,368
-6% -$3.61M 0.12% 144
2023
Q2
$57.8M Sell
164,129
-11,535
-7% -$4.06M 0.13% 139
2023
Q1
$55.3M Buy
175,664
+12,001
+7% +$3.78M 0.13% 140
2022
Q4
$47.3M Sell
163,663
-11,507
-7% -$3.32M 0.12% 153
2022
Q3
$50.7M Buy
175,170
+14,239
+9% +$4.12M 0.15% 139
2022
Q2
$45.3M Buy
160,931
+16,201
+11% +$4.57M 0.12% 161
2022
Q1
$37.8M Sell
144,730
-14,792
-9% -$3.86M 0.08% 194
2021
Q4
$35M Sell
159,522
-19,656
-11% -$4.32M 0.08% 194
2021
Q3
$32.5M Buy
179,178
+37,885
+27% +$6.87M 0.08% 202
2021
Q2
$28.5M Buy
141,293
+20,403
+17% +$4.11M 0.07% 217
2021
Q1
$26M Buy
120,890
+8,816
+8% +$1.89M 0.07% 204
2020
Q4
$26.5M Buy
112,074
+11,937
+12% +$2.82M 0.08% 186
2020
Q3
$27.2M Sell
100,137
-5,440
-5% -$1.48M 0.09% 149
2020
Q2
$30.7M Buy
105,577
+30,833
+41% +$8.95M 0.11% 143
2020
Q1
$17.8M Sell
74,744
-15,326
-17% -$3.65M 0.09% 153
2019
Q4
$19.7M Sell
90,070
-14,013
-13% -$3.07M 0.08% 176
2019
Q3
$17.6M Sell
104,083
-6,728
-6% -$1.14M 0.08% 171
2019
Q2
$20.3M Sell
110,811
-5,617
-5% -$1.03M 0.1% 167
2019
Q1
$21.4M Buy
116,428
+1,174
+1% +$216K 0.11% 155
2018
Q4
$19.1M Sell
115,254
-14,048
-11% -$2.33M 0.1% 169
2018
Q3
$24.9M Sell
129,302
-10,602
-8% -$2.04M 0.12% 153
2018
Q2
$23.8M Buy
139,904
+6,799
+5% +$1.16M 0.11% 155
2018
Q1
$21.7M Sell
133,105
-56,839
-30% -$9.26M 0.11% 157
2017
Q4
$28.5M Sell
189,944
-17,388
-8% -$2.61M 0.14% 151
2017
Q3
$31.5M Sell
207,332
-24,813
-11% -$3.77M 0.16% 133
2017
Q2
$29.9M Sell
232,145
-104,719
-31% -$13.5M 0.16% 117
2017
Q1
$36.8M Sell
336,864
-3,722
-1% -$407K 0.16% 107
2016
Q4
$25.1M Buy
340,586
+58,750
+21% +$4.33M 0.13% 119
2016
Q3
$24.6M Buy
281,836
+25,434
+10% +$2.22M 0.11% 117
2016
Q2
$22.1M Sell
256,402
-14,403
-5% -$1.24M 0.11% 107
2016
Q1
$21.5M Buy
270,805
+18,851
+7% +$1.5M 0.15% 120
2015
Q4
$31.7M Buy
251,954
+803
+0.3% +$101K 0.25% 101
2015
Q3
$26.2M Sell
251,151
-31,626
-11% -$3.29M 0.2% 111
2015
Q2
$34.9M Buy
282,777
+1,315
+0.5% +$162K 0.21% 119
2015
Q1
$33.2M Buy
281,462
+34,779
+14% +$4.1M 0.19% 115
2014
Q4
$29.3M Sell
246,683
-11,988
-5% -$1.42M 0.18% 116
2014
Q3
$29.1M Sell
258,671
-42,648
-14% -$4.79M 0.15% 126
2014
Q2
$28.5M Sell
301,319
-59,317
-16% -$5.62M 0.13% 128
2014
Q1
$25.5M Buy
360,636
+47,283
+15% +$3.34M 0.13% 128
2013
Q4
$23.3M Buy
313,353
+70,918
+29% +$5.27M 0.12% 129
2013
Q3
$18.4M Buy
242,435
+62,629
+35% +$4.75M 0.09% 122
2013
Q2
$14.4M Buy
+179,806
New +$14.4M 0.08% 122